Literature DB >> 22964239

Interactions of the humoral pattern recognition molecule PTX3 with the complement system.

Andrea Doni1, Cecilia Garlanda, Barbara Bottazzi, Seppo Meri, Peter Garred, Alberto Mantovani.   

Abstract

The innate immune system comprises a cellular and a humoral arm. The long pentraxin PTX3 is a fluid phase pattern recognition molecule, which acts as an essential component of the humoral arm of innate immunity. PTX3 has antibody-like properties including interactions with complement components. PTX3 interacts with C1q, ficolin-1 and ficolin-2 as well as mannose-binding lectin, recognition molecules in the classical and lectin complement pathways. The formation of these heterocomplexes results in cooperative pathogen recognition and complement activation. Interactions with C4b binding protein and factor H, the principal regulators of the classical, lectin and alternative complement pathways, show that PTX3 also may have a major influence on the regulation of the complement system. The complex interaction of PTX3 with the complement system at different levels has broad implications for host defence and regulation of inflammation.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964239     DOI: 10.1016/j.imbio.2012.07.004

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  30 in total

1.  Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.

Authors:  Jai-Nien Tung; Chung-Po Ko; Shun-Fa Yang; Chun-Wen Cheng; Pei-Ni Chen; Chia-Yu Chang; Chia-Liang Lin; Te-Fang Yang; Yi-Hsien Hsieh; Kun-Chung Chen
Journal:  J Neurooncol       Date:  2016-06-09       Impact factor: 4.130

2.  Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.

Authors:  Adriana Marques; Ira Schwartz; Gary P Wormser; Yanmei Wang; Ronald L Hornung; Cumhur Y Demirkale; Peter J Munson; Siu-Ping Turk; Carla Williams; Chyi-Chia Richard Lee; Jun Yang; Mary M Petzke
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

Review 3.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

Review 4.  Complement in immune and inflammatory disorders: pathophysiological mechanisms.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

5.  PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.

Authors:  Cecilia Garlanda; Barbara Bottazzi; Elena Magrini; Antonio Inforzato; Alberto Mantovani
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 6.  Innate immunity, hemostasis and matrix remodeling: PTX3 as a link.

Authors:  Andrea Doni; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunol       Date:  2016-11-20       Impact factor: 11.130

Review 7.  PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition.

Authors:  Cecilia Garlanda; Sebastien Jaillon; Andrea Doni; Barbara Bottazzi; Alberto Mantovani
Journal:  Curr Opin Immunol       Date:  2015-11-30       Impact factor: 7.486

Review 8.  Pentraxins in the activation and regulation of innate immunity.

Authors:  Kenji Daigo; Antonio Inforzato; Isabella Barajon; Cecilia Garlanda; Barbara Bottazzi; Seppo Meri; Alberto Mantovani
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

9.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 10.  Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases.

Authors:  Fabrizia Bonacina; Andrea Baragetti; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Mediators Inflamm       Date:  2013-04-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.